Endothelium-targeted myc silencing suppresses pathological ocular neovascularization.
Ocular neovascularization (NV) causes blindness, yet anti-VEGF therapy has limited efficacy. Myc controls endothelial cell (EC) proliferation and activation, however, its pathological role in ocular NV and therapeutic value remain unclear. In this study, we found that Myc was markedly upregulated in neovascular ECs (NV...